Upon multivariate analysis, high MAP17 expression (HR: 1.710; 95% CI, 1.156-2.449; p = 0.012), large tumor size (> 5 cm) (HR, 2.339; 95% CI, 1.468-3.726; p < 0.001), and high serum AST level (> 40 U/L) (HR, 1.863; 95% CI, 1.286-2.699; p = 0.001) were independent prognostic factors of DFS in patients with HCC (Table 3). The gene discussed is PDZK1IP1; the disease is hepatocellular carcinoma.